Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000902664-25-004499
Filing Date
2025-10-21
Accepted
2025-10-21 19:00:03
Documents
1
Period of Report
2025-10-14

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 12147
  Complete submission text file 0000902664-25-004499.txt   14656
Mailing Address 151 CALLE DE SAN FRANCISCO SUITE 200, PMB 1237 SAN JUAN PR 00901-1607
Business Address
Nichols Weston (Reporting) CIK: 0001746376 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39856 | Film No.: 251408276

Mailing Address ONE MAIN STREET SUITE 1350 CAMBRIDGE MA 02142
Business Address ONE MAIN STREET SUITE 1350 CAMBRIDGE MA 02142 617-410-4650
Cullinan Therapeutics, Inc. (Issuer) CIK: 0001789972 (see all company filings)

EIN.: 813879991 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address D81 CALLE C SUITE 301 PMB 1202 DORADO Puerto Rico 00646
Business Address D81 CALLE C SUITE 301 PMB 1202 DORADO Puerto Rico 00646 703-963-7214
Lynx1 Capital Management LP (Reporting) CIK: 0001910456 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
LEI: 5493003YH8Q5SHT17216
Type: 4 | Act: 34 | File No.: 001-39856 | Film No.: 251408277